CRO

Crown Bioscience

Accepting studies

Oncology & immuno-oncology in vivo models leader.

Preclinical / GLP laboratoryTaicang, Jiangsu, ChinaChinaEst. 2006 · 20y1,600 staffWebsite

Overview Capabilities Study capabilities Animal models Regulatory Locations Team

Capabilities & focus

Modalities

Small moleculesBiologicsCell & gene therapyAntibody-drug conjugates

 Species supported

MouseRat

Therapeutic focus

OncologyImmuno-oncologyMetabolic

Technology platforms

Next-gen sequencingFlow cytometryBiomarker multiplexImaging (PET/SPECT/MRI)

Study scope

Efficacy / pharmacologyBiomarkerBiodistribution

2006

Founded

Subsidiary

Ownership

—

Global sites

—

Study rooms

—

Turnaround

BSL-2

Biosafety

CRO

Crown Bioscience

Preclinical / GLP · China

Live record · illustrative seed data · scores deterministic, rules-based — not AI · regulatory signals are educational, not a compliance determination.